用先进的传递系统准代谢漏洞.
Wanlin Ye1, Xin Li1, Jocelyn Chandra1
1Department of Pharmaceutical Science, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, P.R. China; Department of Biomedical Sciences, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, P.R. China.
精确瘤学通过准癌细胞代谢来取得进展. 新的代谢调节药物递送系统 (MDDS) 提供了有针对性的干预措施,克服了临床翻译的先前局限性.
科学领域:
- 在瘤学瘤学.
- 代谢工程是代谢工程.
- 药物输送系统 药物输送系统
背景情况:
- 代谢调节是精密瘤学的关键策略.
- 在体内针对癌细胞独特的代谢脆弱性仍然是一个重大挑战.
- 先进的输送系统正在实现有针对性的代谢干预.
研究的目的:
- 评估代谢调节药物递送系统 (MDDS) 在精密瘤学的进展情况.
- 突出MDDS在临床转化中的前进道路.
- 讨论转化障碍,并为开发基于代谢的疗法提出解决方案.
主要方法:
- 审查目前的策略,将瘤代谢与先进的输送系统相结合.
- 分析关键的转化障碍,包括代谢异质性,生物障碍和非目标效应.
- 探索新兴解决方案,如代谢电路映射和人工智能驱动的载体设计.
主要成果:
- 在精确瘤学中,MDDS显示出有希望的针对性代谢干预.
- 显著的翻译障碍阻碍了临床应用.
- 新兴的解决方案提供了克服这些挑战的潜力.
结论:
- 在精密瘤学中,MDDS代表了一个有前途的前沿.
- 解决翻译障碍对于临床成功至关重要.
- 需要创新的方法来推进基于代谢的治疗方法.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Influencing Factors
Bioavailability Enhancement: Drug Permeability Enhancement
Oral Drug Delivery Systems: Continuous-Release Systems
